Sellbyville, Delaware, Dec. 19, 2018 (GLOBE NEWSWIRE) --
Germany ophthalmic viscosurgical devices market is projected to show lucrative CAGR of 12% over the forecast timeline. Rising incidence of ophthalmic diseases in the country will favor business growth in the foreseeable future. Furthermore, organizations such as German Society of Ophthalmology, German Professional Association of Ophthalmologists and the Association of German Ophthalmic Surgeons are implementing national screening programs for glaucoma. Additionally, it also includes age-related macular degeneration and other age-related conditions that will further augment industry growth.
Global Ophthalmic Viscosurgical Devices Market will surpass USD 790 million by 2024; according to a new research report by Global Market Insights, Inc. Increasing number of people suffering from different types of ophthalmic disorders is the key factor driving OVD industry growth during the forthcoming years. Moreover, diabetic patients are at high risk of suffering from some or the other ophthalmic disease. Increasing prevalence of diabetes in developed as well as developed economies will further spur the market growth.
Diminishing visual functions with increasing age is a growing concern among the elderly population base. Prevalence and incidence of blindness, vision impairment and other ophthalmic disorders such as diabetic retinopathy, cataract, macular degeneration and glaucoma is high among aged people as compared to the younger population. Rapidly growing geriatric population base will boost the demand for ophthalmic surgeries thereby, accelerating OVD business growth. However, risks associated with eye surgeries such as irregular astigmatism, epithelial ingrowth and diffuse lamellar keratitis (DLK) may impede OVD market growth in the coming years.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1134
Cataract surgery segment held considerable revenue share in 2017 and will witness lucrative CAGR of 12.8% over the analysis period. High segment growth is attributable to increasing prevalence of disease coupled with rising geriatric population across the globe. According to International Agency for the Prevention of Blindness (IAPB), cataract is the leading cause of blindness across the world. Growing incidence of cataract will surge the need for cataract surgeries worldwide thereby accelerating segment growth in the coming years.
Dispersive segment dominated the ophthalmic viscosurgical devices market with USD 170.2 million in 2017 and is estimated to show robust growth over the forecast timeframe. Increasing adoption of dispersive OVDs in iris trauma, capsular rupture or zonular weakness, to create and maintain separation between anterior and posterior segments will favor segmental growth during the forecast period.
Browse key industry insights spread across 145 pages with 172 market data tables & 8 figures & charts from the report, “Ophthalmic Viscosurgical Devices (OVD) Market” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/ophthalmic-viscosurgical-devices-market
Hospitals segment accounted for 44.8% revenue share in 2017 and the segment will witness robust CAGR in the coming years. Increasing patient preference towards non-invasive and technologically advanced surgical procedures performed in hospital settings will propel segmental growth. Furthermore, hospitals are equipped with advanced technology-integrated medical devices for cataract and other vision correction procedures that will further accelerate industry growth.
U.S. ophthalmic viscosurgical devices market dominated North America region and was valued at USD 156.1 million in 2017 and is estimated to witness similar trend in the coming years. High growth is attributed to increasing prevalence of diabetes among the population leading to visual disabilities. Awareness among people regarding regular eye check-up coupled with high healthcare expenditure will spur U.S. OVD market size over the forecast period.
Prominent industry players operating in the global market include Abbott Medical Optics, Alcon, Bohus Biotech, Bausch & Lomb, Carl Zeiss Meditec, CIMA Technology, Johnson & Johnson Vision Care, Maxigen Biotech, Precision Lens, Rayner Intraocular Lenses and Sidapharm. Key industry players majorly focus on several strategic initiatives including new product launch, partnership, merger and acquisitions to strengthen their market position and capitalize on market opportunities. For instance, in October 2018, Carl Zeiss announced agreement to acquire IanTech a company focused on technological solutions for micro interventional cataract surgeries.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1134
Browse Related Reports:
- Ophthalmic Devices Market Size Forecast 2018 – 2024
The Ophthalmic Devices Market exceeded USD 41.5 billion in 2017 and is expected to witness more than 3.7% CAGR from 2018 to 2024 as increase in number of people suffering from ophthalmic disorders will propel the industry growth.
https://www.gminsights.com/industry-analysis/ophthalmic-devices-market
- Microsurgery Robot Market Size Outlook 2018 – 2024
Global Microsurgery Robot Market surpassed USD 0.7 billion in 2017 and is expected to witness more than 13.9% CAGR from 2018 to 2024 as technological advancements in microsurgery robot allowing effective treatment of various chronic disorders will fuel the market growth.
https://www.gminsights.com/industry-analysis/microsurgery-robot-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.